U.S. markets closed
  • S&P 500

    4,567.00
    -88.27 (-1.90%)
     
  • Dow 30

    34,483.72
    -652.22 (-1.86%)
     
  • Nasdaq

    15,537.69
    -245.14 (-1.55%)
     
  • Russell 2000

    2,198.91
    -43.07 (-1.92%)
     
  • Crude Oil

    67.00
    -2.95 (-4.22%)
     
  • Gold

    1,773.30
    -9.00 (-0.50%)
     
  • Silver

    22.79
    -0.01 (-0.04%)
     
  • EUR/USD

    1.1342
    +0.0049 (+0.43%)
     
  • 10-Yr Bond

    1.4430
    -0.0870 (-5.69%)
     
  • GBP/USD

    1.3300
    -0.0012 (-0.09%)
     
  • USD/JPY

    113.0950
    -0.5130 (-0.45%)
     
  • BTC-USD

    57,264.14
    -1,113.09 (-1.91%)
     
  • CMC Crypto 200

    1,456.40
    +13.62 (+0.94%)
     
  • FTSE 100

    7,059.45
    -50.50 (-0.71%)
     
  • Nikkei 225

    27,821.76
    -462.16 (-1.63%)
     

OSCR Alert: Johnson Fistel Launches Investigation into OscarHealth; Investors Suffering Losses Encouraged to Contact the Firm

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

SAN DIEGO, June 8, 2021 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against Oscar Health, Inc. (NYSE: OSCR) ("Oscar" or the "Company") for violations of federal securities laws.

On or about March 3, 2021, Oscar sold about 37 million shares of stock in its initial public stock offering (the "IPO") at $39.00 a share, raising nearly $1.4 billion in new capital. On June 7, 2021, the stock closed at $28.68.

On May 13, 2021, Oscar reported earnings for the first time since the IPO. The Company reported an $87.4 million loss or $(0.98) per share in its first quarter of 2021. Analysts polled by FactSet had expected Oscar to report a loss of 53 cents a share.

Specifically, Johnson Fistel's investigation seeks to determine whether the Company's filings with the U.S. Securities and Exchange Commission in connection with its March 2021 IPO and subsequent investor communications contained untrue statements of material facts or omitted to state other facts necessary to make the statements made therein not misleading concerning the Company's business, and operations.

If you have information that could assist in this investigation, or if you are an Oscar shareholder and are interested in learning more about the investigation, please contact Jim Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing, please include a phone number.
Additionally, you can [click here to join this action]. There is no cost or obligation to you.

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
jimb@johnsonfistel.com

[click here to join this action]

Cision
Cision

View original content:http://www.prnewswire.com/news-releases/oscr-alert-johnson-fistel-launches-investigation-into-oscarhealth-investors-suffering-losses-encouraged-to-contact-the-firm-301308552.html

SOURCE Johnson Fistel, LLP